Insider · CIK 0001583098

DeGolyer Donald W

Reports to the SEC for 4 companies · GAITHERSBURG, MD

sec.gov

Transactions

Companies

Filings

CIK

0001583098

Forms 4 and 5

Insider transactions

40 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-07	EBSEmergent BioSolutions Inc.S Sale	Director	SSale	−17.8K sh	$7.09	−$126K	111,921
2026-05-01	EBSEmergent BioSolutions Inc.S Sale	Director	SSale	−14.5K sh	$8.36	−$121K	130,675
2026-05-01	EBSEmergent BioSolutions Inc.S Sale	Director	SSale	−954 sh	$8.96	−$8,547.84	129,721
2026-04-30	EBSEmergent BioSolutions Inc.A Award	Director	AAward	+25.3K sh	—	—	145,202
2026-04-30	EBSEmergent BioSolutions Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+11.3K sh	—	—	11,296
2025-11-10	EBSEmergent BioSolutions Inc.S Sale	Director	SSale	−17.8K sh	$10.54	−$188K	119,858
2025-08-12	EBSEmergent BioSolutions Inc.S Sale	Director	SSale	−7,844 sh	$8.65	−$67.8K	137,659
2025-04-30	EBSEmergent BioSolutions Inc.A Award	Director	AAward	+34.4K sh	—	—	145,503
2025-04-30	EBSEmergent BioSolutions Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15.8K sh	—	—	41,572
2024-11-12	EBSEmergent BioSolutions Inc.S Sale	Director	SSale	−25K sh	$10.91	−$273K	111,100
2024-05-23	EBSEmergent BioSolutions Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25.7K sh	—	—	25,748
2024-05-23	EBSEmergent BioSolutions Inc.A Award	Director	AAward	+17.4K sh	—	—	136,100
2023-10-03	EBSEmergent BioSolutions Inc.A Award	Director	AAward	+119K sh	—	—	118,670
2022-09-16	TYME TECHNOLOGIES, INC.Director Stock Option - Option to buyD Disposition to Issuer	Director	DDisposition to Issuer	−50K sh	—	—	0
2022-09-16	TYME TECHNOLOGIES, INC.Director Stock Option - Option to buyD Disposition to Issuer	Director	DDisposition to Issuer	−88K sh	—	—	0
2022-09-16	TYME TECHNOLOGIES, INC.Director Stock Option - Option to buyD Disposition to Issuer	Director	DDisposition to Issuer	−88K sh	—	—	0
2022-09-16	TYME TECHNOLOGIES, INC.Director Stock Option - Option to buyD Disposition to Issuer	Director	DDisposition to Issuer	−100K sh	—	—	0
2022-09-16	TYME TECHNOLOGIES, INC.Director Stock Option - Option to buyD Disposition to Issuer	Director	DDisposition to Issuer	−50K sh	—	—	0
2022-09-16	TYME TECHNOLOGIES, INC.Director Stock Option - Option to buyD Disposition to Issuer	Director	DDisposition to Issuer	−65K sh	—	—	0
2022-08-24	TYME TECHNOLOGIES, INC.Director Stock Option - Option to buyA Award	Director	AAward	+88K sh	—	—	88,000
2021-08-24	TYME TECHNOLOGIES, INC.Director Stock Option - Option to buyA Award	Director	AAward	+88K sh	—	—	88,000
2020-08-20	TYME TECHNOLOGIES, INC.Director Stock Option - right to buyA Award	Director	AAward	+65K sh	—	—	65,000
2019-08-22	TYME TECHNOLOGIES, INC.Director Stock Option - right to buyA Award	Director	AAward	+50K sh	—	—	50,000
2018-08-26	TYME TECHNOLOGIES, INC.Director Stock Option - right to buyA Award	Director	AAward	+50K sh	—	—	50,000
2018-05-24	TYME TECHNOLOGIES, INC.Director Stock Option - right to buyA Award	Director	AAward	+100K sh	—	—	100,000
2015-02-26	Endo International plcF Tax Payment	Chief Operating Officer,Pharma	FTax Payment	−477 sh	$85.19	−$40.6K	6,547
2014-08-02	Endo International plcF Tax Payment	Chief Operating Officer,Pharma	FTax Payment	−4,459 sh	$68.10	−$304K	5,743
2014-02-28	ENDO HEALTH SOLUTIONS INC.2010 Stock Incentive Plan Stock Options (NQ)D Disposition to Issuer	Chief Operating Officer,Pharma	DDisposition to Issuer	−19.1K sh	—	—	0
2014-02-28	Endo International plcA Award	Chief Operating Officer,Pharma	AAward	+30.6K sh	—	—	30,604
2014-02-28	Endo International plcA Award	Chief Operating Officer,Pharma	AAward	+5,121 sh	—	—	5,121
2014-02-28	Endo International plcA Award	Chief Operating Officer,Pharma	AAward	+30.6K sh	—	—	30,604
2014-02-28	Endo International plcA Award	Chief Operating Officer,Pharma	AAward	+10.2K sh	—	—	10,242
2014-02-28	Endo International plc2010 Stock Incentive Plan Stock Options (NQ)A Award	Chief Operating Officer,Pharma	AAward	+19.1K sh	—	—	19,081
2014-02-28	ENDO HEALTH SOLUTIONS INC.D Disposition to Issuer	Chief Operating Officer,Pharma	DDisposition to Issuer	−5,121 sh	—	—	0
2014-02-28	ENDO HEALTH SOLUTIONS INC.D Disposition to Issuer	Chief Operating Officer,Pharma	DDisposition to Issuer	−30.6K sh	—	—	0
2014-02-28	ENDO HEALTH SOLUTIONS INC.D Disposition to Issuer	Chief Operating Officer,Pharma	DDisposition to Issuer	−10.2K sh	—	—	0
2014-02-28	ENDO HEALTH SOLUTIONS INC.D Disposition to Issuer	Chief Operating Officer,Pharma	DDisposition to Issuer	−30.6K sh	—	—	0
2014-02-26	ENDO HEALTH SOLUTIONS INC.2010 Stock Incentive Plan Stock OptionsA Award	Chief Operating Officer,Pharma	AAward	+19.1K sh	—	—	19,081
2014-02-26	ENDO HEALTH SOLUTIONS INC.A Award	Chief Operating Officer,Pharma	AAward	+5,121 sh	—	—	35,725
2014-02-26	ENDO HEALTH SOLUTIONS INC.A Award	Chief Operating Officer,Pharma	AAward	+10.2K sh	—	—	40,846

Recent filings

Accepted (ET)
Oct 7 15:454
DeGolyer Donald W0001583098-26-000008
SEC(opens sec.gov)
May 44
DeGolyer Donald W0001583098-26-000004
SEC(opens sec.gov)
Nov 124
DeGolyer Donald W0001583098-25-000005
SEC(opens sec.gov)
Aug 134
DeGolyer Donald W0001628280-25-040156
SEC(opens sec.gov)
May 24
DeGolyer Donald W0001367644-25-000104
SEC(opens sec.gov)
Nov 144
DeGolyer Donald W0001367644-24-000186
SEC(opens sec.gov)
May 284
DeGolyer Donald W0001367644-24-000087
SEC(opens sec.gov)
Oct 54
DeGolyer Donald W0001367644-23-000177
SEC(opens sec.gov)
Sep 164
DeGolyer Donald W0000899243-22-031344
SEC(opens sec.gov)
Aug 294
DeGolyer Donald W0000899243-22-029940
SEC(opens sec.gov)

Companies

Address

300 PROFESSIONAL DR

GAITHERSBURG, MD, 20879